Status:
COMPLETED
Chemotherapy w/wo WeiLeShu in Metastatic Colorectal Cancer
Lead Sponsor:
Zhejiang University
Conditions:
Microbial Colonization
Colorectal Cancer
Eligibility:
All Genders
18-75 years
Phase:
PHASE2
Brief Summary
A total of 50 patients with metastatic colorectal cancer will be enrolled in the study. The patients were randomly divided into the WLS-intervention group and the control group. The two groups of pati...
Eligibility Criteria
Inclusion
- At least 18 years of age, of any race or sex who are eligible to sign written consent and have undergone prior resection of histological evidence of colorectal cancer
- Hematologic function: ANC ≥ 1.5 x 10 /L, platelets ≥ 75 x 10 /L, and hemoglobin \> 9 g/dL Adequate liver function as measured by: total bilirubin ≤ 2.0 mg/dl, AST and ALT ≤ 5 ULN, albumin ≥ 2.5 g/dl Adequate renal function as measured by: creatinine ≤ 2.9 mg/dl, \> 50 ml/min calculated by the C-G equation Non-pregnant women of childbearing potential and fertile men are required to use effective contraception (negative pregnancy test for women of child-bearing age) ECOG status ≤ 1 at screening
Exclusion
- \-
Key Trial Info
Start Date :
July 11 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 30 2021
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04021589
Start Date
July 11 2019
End Date
October 30 2021
Last Update
January 30 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
First affiliated hospital, Zhejiang University
Hangzhou, Zhejiang, China, 310006